Delstrigo 300 mg (Lamivudine TABLET) 300 MG

DELSTRIGO 300 MG tablets contain lamivudine, an antiviral medication used to manage HIV infections. This oral treatment is manufactured by Merck Canada Inc. and is available in a 30-tablet pack.

Strength

300 MG

Pack Size

Manufacturer / TM Owner

MERCK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

DELSTRIGO 300 MG tablets are primarily used in the treatment of HIV infections. Lamivudine, the active ingredient, works by inhibiting the replication of the HIV virus. This medication is often part of a combination therapy to manage HIV and improve immune function. Patients should consult their healthcare provider to determine if DELSTRIGO 300 MG is suitable for their specific condition.

Side Effects

Common effects of DELSTRIGO 300 MG tablets may include headaches, nausea, and fatigue. Some users might experience dizziness or insomnia. These effects vary among individuals and are not experienced by everyone. If any effects persist or worsen, it is advisable to seek medical advice.

Precautions & Warnings

DELSTRIGO 300 MG tablets should be stored at room temperature, away from moisture and heat. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with known allergies to lamivudine or any of the inactive ingredients should avoid this medication. Pregnant or breastfeeding women should consult their healthcare provider before use.

Avoid Interactions

DELSTRIGO 300 MG tablets may interact with other medications, including certain antiviral drugs and immune modulators. Alcohol consumption should be avoided as it may exacerbate side effects. Patients taking other medications should inform their healthcare provider to avoid potential interactions. Always consult a healthcare professional before starting any new medication.

Frequently Asked Questions

DELSTRIGO 300 MG tablets are used in the treatment of HIV infections as part of a combination therapy.

DELSTRIGO 300 MG tablets should be stored at room temperature, away from moisture and heat.

Common effects may include headaches, nausea, fatigue, dizziness, and insomnia.

DELSTRIGO 300 MG may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Pregnant women should consult their healthcare provider before taking DELSTRIGO 300 MG.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.